Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Captopril and hydrochlorothiazide: rationale for their combination.

E Ambrosioni, C Borghi, F V Costa

    British Journal of Clinical Pharmacology
    |January 1, 1987
    PubMed
    Summary

    Combining captopril and thiazide diuretics effectively lowers blood pressure in most hypertensive patients. This combination enhances cellular ionic changes, improving vascular tone and reducing hypertension.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Screening of hypercortisolism among patients with hypertension: an Italian nationwide survey.

    Journal of endocrinological investigation·2024
    Same author

    Corrigendum to "Natural mutations of human XDH promote the nitrite (NO<sub>2</sub><sup>-</sup>)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health?" [Redox Biol. 4 (67) (2023) 102864].

    Redox biology·2023
    Same author

    Natural mutations of human XDH promote the nitrite (NO<sub>2</sub><sup>-</sup>)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health?

    Redox biology·2023
    Same author

    Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension.

    Journal of internal medicine·2023
    Same author

    Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up.

    Nutrition, metabolism, and cardiovascular diseases : NMCD·2022
    Same author

    Are monotherapies still valuable to the treatment of hypertension?

    Expert opinion on pharmacotherapy·2020

    Area of Science:

    • Cardiovascular Pharmacology
    • Nephrology
    • Internal Medicine

    Background:

    • Hypertension affects a significant portion of the population.
    • Thiazide diuretics and captopril are common antihypertensive agents.
    • The synergistic mechanism of action between these drugs requires further elucidation.

    Purpose of the Study:

    • To investigate the combined mechanism of action of captopril and thiazide diuretics in hypertensive patients.
    • To explore the cellular ionic changes induced by this drug combination.
    • To correlate these changes with blood pressure reduction and vascular tone.

    Main Methods:

    • Controlled clinical studies were conducted.
    • Intracellular sodium (Nai) and intra- and extracellular potassium (Ki, Ke) levels were measured.

    Related Experiment Videos

  • Changes in the Ki/Ke ratio and its relation to vascular smooth muscle membrane potential were analyzed.

    • Main Results:

    • Combination therapy resulted in satisfactory blood pressure reduction in approximately 80% of patients.
    • Thiazides reduced Nai and altered Ki/Ke ratio.
    • Captopril also reduced Nai and increased Ki/Ke ratio, with additive effects when combined with thiazides.
    • These ionic shifts correlate with reduced vascular sensitivity to catecholamines and angiotensin, and hyperpolarization of vascular smooth muscle.

    Conclusions:

    • The combination of captopril and thiazides offers an additive effect on intracellular sodium reduction and increases the Ki/Ke ratio.
    • These ionic alterations contribute to the significant blood pressure reduction observed in hypertensive patients.
    • The combination therapy demonstrates favorable metabolic effects alongside antihypertensive efficacy.